The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11

Abstract Background Candida albicans, the main human fungal pathogen, can cause fungal infection and seriously affect people's health and life. This study aimed to investigate the effects of ritonavir (RIT) on C. albicans and the correlation between SAP2 as well as ERG11 and drug resistance. Re...

Full description

Bibliographic Details
Main Authors: Wenli Feng, Jing Yang, Yan Ma, Zhiqin Xi, Xiaoqin Zhao, Xiaoxia Zhao, Min Zhao
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.415
_version_ 1819128766885003264
author Wenli Feng
Jing Yang
Yan Ma
Zhiqin Xi
Xiaoqin Zhao
Xiaoxia Zhao
Min Zhao
author_facet Wenli Feng
Jing Yang
Yan Ma
Zhiqin Xi
Xiaoqin Zhao
Xiaoxia Zhao
Min Zhao
author_sort Wenli Feng
collection DOAJ
description Abstract Background Candida albicans, the main human fungal pathogen, can cause fungal infection and seriously affect people's health and life. This study aimed to investigate the effects of ritonavir (RIT) on C. albicans and the correlation between SAP2 as well as ERG11 and drug resistance. Results Secreted aspartyl proteinases (Saps) activities and pathogenicity of C. albicans with different drug resistance were measured. M27‐A4 broth microdilution method was used to analyze the drug sensitivity of RIT combined with fluconazole (FCA) on C. albicans. After that, SAP2 and ERG11 mutations were examined by polymerase chain reaction (PCR) and sequencing, and quantitative real‐time PCR was utilized to determine the expression of the two genes. By analyzing pz values, the Saps activity of cross‐resistant strains was the highest, followed by voriconazole (VRC)‐resistant strains, FCA‐resistant strains, itraconazole (ITR)‐resistant strains, and sensitive strains. The pathogenicity of C. albicans in descending order was as follows: cross‐resistant strains, VRC‐resistant strains, ITR‐resistant strains, FCA‐resistant strains, and sensitive strains. With the increase of RIT concentrations, the Saps activity was gradually inhibited. Drug sensitivity results showed that there was no synergistic effect between RIT and FCA. Additionally, no gene mutation sites were found in SAP2 sequencing, and 17 synonymous mutations and 6 missense mutations occurred in ERG11 sequencing. Finally, the expression of SAP2 and ERG11 was significantly higher in the resistant strains compared with the sensitive strains, and there was a positive liner correlation between SAP2 and ERG11 messenger RNA expression (r = .6655, p < .001). Conclusion These findings may help to improve our understanding of azole‐resistant mechanisms of C. albicans and provide a novel direction for clinical therapeutics of C. albicans infection.
first_indexed 2024-12-22T08:33:03Z
format Article
id doaj.art-66a941da1a9345ab928d84f6faeeabc4
institution Directory Open Access Journal
issn 2050-4527
language English
last_indexed 2024-12-22T08:33:03Z
publishDate 2021-09-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj.art-66a941da1a9345ab928d84f6faeeabc42022-12-21T18:32:26ZengWileyImmunity, Inflammation and Disease2050-45272021-09-019366768010.1002/iid3.415The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11Wenli Feng0Jing Yang1Yan Ma2Zhiqin Xi3Xiaoqin Zhao4Xiaoxia Zhao5Min Zhao6The Department of Dermatovenereology The Second Hospital of Shanxi Medical University Taiyuan Shanxi ChinaThe Department of Dermatovenereology The Second Hospital of Shanxi Medical University Taiyuan Shanxi ChinaThe Department of Dermatovenereology The Second Hospital of Shanxi Medical University Taiyuan Shanxi ChinaThe Department of Dermatovenereology The Second Hospital of Shanxi Medical University Taiyuan Shanxi ChinaThe Department of Dermatovenereology The Second Hospital of Shanxi Medical University Taiyuan Shanxi ChinaThe Department of Dermatovenereology The Second Hospital of Shanxi Medical University Taiyuan Shanxi ChinaThe Department of Dermatovenereology The Second Hospital of Shanxi Medical University Taiyuan Shanxi ChinaAbstract Background Candida albicans, the main human fungal pathogen, can cause fungal infection and seriously affect people's health and life. This study aimed to investigate the effects of ritonavir (RIT) on C. albicans and the correlation between SAP2 as well as ERG11 and drug resistance. Results Secreted aspartyl proteinases (Saps) activities and pathogenicity of C. albicans with different drug resistance were measured. M27‐A4 broth microdilution method was used to analyze the drug sensitivity of RIT combined with fluconazole (FCA) on C. albicans. After that, SAP2 and ERG11 mutations were examined by polymerase chain reaction (PCR) and sequencing, and quantitative real‐time PCR was utilized to determine the expression of the two genes. By analyzing pz values, the Saps activity of cross‐resistant strains was the highest, followed by voriconazole (VRC)‐resistant strains, FCA‐resistant strains, itraconazole (ITR)‐resistant strains, and sensitive strains. The pathogenicity of C. albicans in descending order was as follows: cross‐resistant strains, VRC‐resistant strains, ITR‐resistant strains, FCA‐resistant strains, and sensitive strains. With the increase of RIT concentrations, the Saps activity was gradually inhibited. Drug sensitivity results showed that there was no synergistic effect between RIT and FCA. Additionally, no gene mutation sites were found in SAP2 sequencing, and 17 synonymous mutations and 6 missense mutations occurred in ERG11 sequencing. Finally, the expression of SAP2 and ERG11 was significantly higher in the resistant strains compared with the sensitive strains, and there was a positive liner correlation between SAP2 and ERG11 messenger RNA expression (r = .6655, p < .001). Conclusion These findings may help to improve our understanding of azole‐resistant mechanisms of C. albicans and provide a novel direction for clinical therapeutics of C. albicans infection.https://doi.org/10.1002/iid3.415Candida albicansERG11SAP2secreted aspartyl proteinases
spellingShingle Wenli Feng
Jing Yang
Yan Ma
Zhiqin Xi
Xiaoqin Zhao
Xiaoxia Zhao
Min Zhao
The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11
Immunity, Inflammation and Disease
Candida albicans
ERG11
SAP2
secreted aspartyl proteinases
title The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11
title_full The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11
title_fullStr The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11
title_full_unstemmed The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11
title_short The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11
title_sort effects of secreted aspartyl proteinase inhibitor ritonavir on azoles resistant strains of candida albicans as well as regulatory role of sap2 and erg11
topic Candida albicans
ERG11
SAP2
secreted aspartyl proteinases
url https://doi.org/10.1002/iid3.415
work_keys_str_mv AT wenlifeng theeffectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT jingyang theeffectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT yanma theeffectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT zhiqinxi theeffectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT xiaoqinzhao theeffectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT xiaoxiazhao theeffectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT minzhao theeffectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT wenlifeng effectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT jingyang effectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT yanma effectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT zhiqinxi effectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT xiaoqinzhao effectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT xiaoxiazhao effectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11
AT minzhao effectsofsecretedaspartylproteinaseinhibitorritonavironazolesresistantstrainsofcandidaalbicansaswellasregulatoryroleofsap2anderg11